TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22805107

Group type: EXPERIMENTAL
Intervention: Concentrated beetroot juice (140 ml, 8.7 mmol NO3‐)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (nitrate‐depleted beetroot juice)
Number of subjects: 20
Study: 19922893

Group type: EXPERIMENTAL
Intervention: Test formulation of imatinib 400 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reference formulation of imatinib 400 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 30
Study: 17876497

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 500 IU/kg/day for three days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 15606396

Group type: EXPERIMENTAL
Intervention: CDP870 10 mg/kg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CDP870 5 mg/kg
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CDP870 20 mg/kg
Number of subjects: 92
Study: 11125881

Group type: EXPERIMENTAL
Intervention: Abacavir and one protease inhibitor
Number of subjects: 71
Study: 9032837

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 0
Study: 7964254

Group type: EXPERIMENTAL
Intervention: Pumpkin seeds snack
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basal mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 0
Study: 3456942

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 (PGE2) gel
Number of subjects: 76

Group type: COMPARATOR
Intervention: Intraamniotic prostaglandin F2 alpha (PGF2 alpha)
Number of subjects: 76
Study: 3180669

Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 37

Group type: COMPARATOR
Intervention: sodium iothalamate
Number of subjects: 37
Study: 31046812

Group type: EXPERIMENTAL
Intervention: Treadmill gait training with anterior inclination of 5%
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Treadmill gait training with anterior inclination of 10%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Treadmill gait training without inclination (control group)
Number of subjects: 36
Study: 28460259

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40mg SQ daily
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Enoxaparin 60mg SQ daily
Number of subjects: 91

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 91
Study: 26291847

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 164
Study: 23273888

Group type: EXPERIMENTAL
Intervention: Rifaximin 25mg/5 days
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Rifaximin 100mg/2 days
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Rifaximin 100mg/5 days
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 21519928

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 64
Study: 17673219

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg/day)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10-80 mg/day)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Atorvastatin-Placebo group
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 134
Study: 17268397

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 12604544

Group type: EXPERIMENTAL
Intervention: 1-day treatment with 2 g of valacyclovir twice daily for 1 day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-day treatment with 2 g of valacyclovir twice daily for 1 day and then 1 g of valacyclovir twice daily for 1 day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valacyclovir (both treatment regimens)
Number of subjects: 0
Study: 10618555

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention targeting depression and/or low social support
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Standard care (control group not explicitly mentioned)
Number of subjects: 3000
Study: 9366460

Group type: EXPERIMENTAL
Intervention: Sevoflurane (0.3% and 0.60%)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (15% and 30%)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (100% oxygen)
Number of subjects: 12
Study: 1555557

Group type: EXPERIMENTAL
Intervention: One-legged exercise (trained limb)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: One-legged exercise (untrained limb)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control limbs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Untrained limb
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trained limb
Number of subjects: 20
Study: 3982804

Group type: EXPERIMENTAL
Intervention: Group A (Van Lint eyelid block and superior rectus bridle suture)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group D (Nadbath block and episcleral retraction suture)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group B (Van Lint block and episcleral retraction suture)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group C (Nadbath retroauricular facial nerve block and superior rectus bridle suture)
Number of subjects: 0
Study: 29860335

Group type: EXPERIMENTAL
Intervention: Betaine 3300 mg orally twice daily for 10 days, then 4950 mg twice daily for 12 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 27789938

Group type: EXPERIMENTAL
Intervention: Health Empowerment Intervention for Stroke Self‐management (HEISS)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual ambulatory rehabilitation care (Control Group)
Number of subjects: 210
Study: 24665995

Group type: EXPERIMENTAL
Intervention: Tofacitinib treatment for 4 weeks
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Tofacitinib plus methotrexate
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Tofacitinib treatment
Number of subjects: 14
Study: 22586173

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 mg
Number of subjects: 456

Group type: COMPARATOR
Intervention: Triamcinolone acetonide 40 mg
Number of subjects: 456
Study: 19683399

Group type: EXPERIMENTAL
Intervention: 30 mg cortisol (hydrocortisone)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 18654733

Group type: EXPERIMENTAL
Intervention: External Qigong Therapy (EQT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Sham Treatment (Control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: All groups (EQT and Control)
Number of subjects: 112
Study: 16309707

Group type: EXPERIMENTAL
Intervention: Safety hall combined with mandatory skid training
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Control group (no safety hall training)
Number of subjects: 1326
Study: 12494034

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg/day) for 1 month
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (12.5 mg/day) in 5 patients
Number of subjects: 30
Study: 11097601

Group type: COMPARATOR
Intervention: Control group (fewer than 15 small drusen)
Number of subjects: 4519

Group type: EXPERIMENTAL
Intervention: Intermediate drusen, extensive small drusen, or pigment abnormalities (group 2)
Number of subjects: 4519

Group type: EXPERIMENTAL
Intervention: One or more large drusen or extensive intermediate drusen (group 3)
Number of subjects: 4519

Group type: EXPERIMENTAL
Intervention: Neovascular AMD (group 5)
Number of subjects: 4519

Group type: EXPERIMENTAL
Intervention: Geographic atrophy (group 4)
Number of subjects: 4519
Study: 8647493

Group type: EXPERIMENTAL
Intervention: Higher amount of cholesterol in red cell membranes
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cholesterol amount in red cell membranes
Number of subjects: 24
Study: 1286739

Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 10
Study: 3782679

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of 0.5 mg epinephrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhalation of 1.5 to 4.5 mg epinephrine (10 to 30 inhalations)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhalation of 2 to 3 mg epinephrine
Number of subjects: 0
Study: 31906814

Group type: EXPERIMENTAL
Intervention: Functional Resistance Training (FRT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional Training (CRT)
Number of subjects: 38
Study: 29952122

Group type: EXPERIMENTAL
Intervention: Digital training system with Online Peer‐Review System (OPRS) and Real‐time Dental Training and Evaluation System (RDTES)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Traditional training method with instructor demonstration and evaluation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Digital training system
Number of subjects: 66
Study: 28784687

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study: 26254513

Group type: EXPERIMENTAL
Intervention: Pioglitazone 7.5 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pioglitazone 15 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pioglitazone 30 mg/day
Number of subjects: 0
Study: 23644909

Group type: EXPERIMENTAL
Intervention: Socket filling with PRF after simple extraction
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Socket filling with PRF after extraction with mucosal flap
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group with simple extraction without socket filling
Number of subjects: 23
Study: 21933431

Group type: EXPERIMENTAL
Intervention: Public commitment activities
Number of subjects: 4603

Group type: EXPERIMENTAL
Intervention: Public commitment activities (overweight or obese subgroup)
Number of subjects: 4603

Group type: EXPERIMENTAL
Intervention: No public commitment activities
Number of subjects: 4603
Study: 18577531

Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard pre-dialysis education
Number of subjects: 70
Study: 16902290

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser
Number of subjects: 16

Group type: COMPARATOR
Intervention: 311-nm UVB phototherapy
Number of subjects: 16
Study: 12807341

Group type: EXPERIMENTAL
Intervention: 400 mg Kava LI 150
Number of subjects: 129

Group type: COMPARATOR
Intervention: 10 mg Buspirone
Number of subjects: 129

Group type: COMPARATOR
Intervention: 100 mg Opipramol
Number of subjects: 129
Study: 10230742

Group type: EXPERIMENTAL
Intervention: Computerized reminders for redundant tests
Number of subjects: 11586

Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 11586

Group type: EXPERIMENTAL
Intervention: Overall effect of reminders
Number of subjects: 11586
Study: 8618182

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (52 micromol or 50,000 IU orally administered at birth)
Number of subjects: 2067

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2067

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 2067
Study: 2016833

Group type: EXPERIMENTAL
Intervention: Antibiotic-bonded catheters (pretreated with tridodecylmethylammonium chloride and immersed in a 50-mg/mL cefazolin solution)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group (standard catheters)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Both groups (antibiotic-bonded and control)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Antibiotic immersion solutions
Number of subjects: 178
Study: 6223151

Group type: EXPERIMENTAL
Intervention: Piperacillin (PIPC) administered by intravenous injection or infusion
Number of subjects: 16
Study: 30907196

Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT) with two samples
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT) positivity
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT) at cut off levels of 10 µg/g and 20 µg/g
Number of subjects: 806
Study: 28438548

Group type: EXPERIMENTAL
Intervention: Interactive reading with puppet
Number of subjects: 163

Group type: COMPARATOR
Intervention: Interactive reading without puppet
Number of subjects: 163

Group type: COMPARATOR
Intervention: Passive reading with puppet
Number of subjects: 163

Group type: COMPARATOR
Intervention: Passive reading without puppet
Number of subjects: 163
Study: 26393910

Group type: EXPERIMENTAL
Intervention: American ginseng tea infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 14
Study: 23415983

Group type: EXPERIMENTAL
Intervention: Self-help Manual
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intention-control
Number of subjects: 80
Study: 22115143

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy (MST)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual services delivered by youth offending teams (YOT)
Number of subjects: 108
Study: 19998453

Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative care intervention (PPCC)
Number of subjects: 58
Study: 18214192

Group type: EXPERIMENTAL
Intervention: Zinc cream
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 50
Study: 15159321

Group type: EXPERIMENTAL
Intervention: 12-month moderate intensity aerobic exercise intervention
Number of subjects: 170

Group type: COMPARATOR
Intervention: Stretching control group
Number of subjects: 170
Study: 11581545

Group type: EXPERIMENTAL
Intervention: Combined exercise and behavioral weight management (WM)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Exercise-only group (EX)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Wait list control group (CON)
Number of subjects: 112
Study: 9734739

Group type: EXPERIMENTAL
Intervention: Meals containing beta-carotene sources (mainly red sweet potatoes) and added fat, with deworming using levamisole.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meals containing beta-carotene sources and added fat without deworming.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meals with added beta-carotene sources and added fat when A. lumbricoides infection was low.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (children who remained infected with A. lumbricoides and did not receive deworming).
Number of subjects: 0
Study: 7825525

Group type: EXPERIMENTAL
Intervention: Mycoprotein
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 2596424

Group type: EXPERIMENTAL
Intervention: Diet Only (DO)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diet with Exercise (DE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (C) - Balanced, moderately low-calorie diet (approximately 1400 kcal/d)
Number of subjects: 24
Study: 653482

Group type: EXPERIMENTAL
Intervention: Exteriorization and closure of the penetrating colon wound
Number of subjects: 34

Group type: COMPARATOR
Intervention: Colostomy
Number of subjects: 34
Study: 31965646

Group type: EXPERIMENTAL
Intervention: Nutrient-dense formula (NDF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Post-discharge formula (PDF)
Number of subjects: 48
Study: 30781543

Group type: EXPERIMENTAL
Intervention: TEI Program (peer tutoring intervention)
Number of subjects: 2057

Group type: COMPARATOR
Intervention: Control group (12 schools, 1070 students)
Number of subjects: 2057
Study: 28900096

Group type: EXPERIMENTAL
Intervention: Billroth-I (B-I) anastomosis
Number of subjects: 140

Group type: COMPARATOR
Intervention: Roux-en-Y (R-Y) anastomosis
Number of subjects: 140
Study: 25824637

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (1,140 mg of EPA + 600 mg of DHA)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (olive oil + safflower oil)
Number of subjects: 35
Study: 25286455

Group type: EXPERIMENTAL
Intervention: Sarcopenia (defined by low muscle mass, low muscle strength, and low physical performance)
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Dynapenia (defined by low handgrip strength)
Number of subjects: 1149

Group type: COMPARATOR
Intervention: No sarcopenia
Number of subjects: 1149

Group type: COMPARATOR
Intervention: No dynapenia
Number of subjects: 1149
Study: 21854132

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt (100 g twice a day/week)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Clindamycin (300 mg twice a day/week)
Number of subjects: 310
Study: 19619424

Group type: EXPERIMENTAL
Intervention: Adhesive system (Scotchbond Multipurpose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Calcium hydroxide liner (Dycal)
Number of subjects: 48
Study: 17593672

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Beclomethasone nasal spray
Number of subjects: 75

Group type: COMPARATOR
Intervention: Steam inhalation (Control)
Number of subjects: 75
Study: 15139896

Group type: EXPERIMENTAL
Intervention: Low glycaemic index diet
Number of subjects: 35

Group type: COMPARATOR
Intervention: High glycaemic index diet
Number of subjects: 35
Study: 12034622

Group type: EXPERIMENTAL
Intervention: Dual-phase helical CT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-phase helical CT
Number of subjects: 60
Study: 11372148

Group type: COMPARATOR
Intervention: Toothbrush
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pako Ijebu (Massularia acuminata)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Orin Ayan (Distemonanthus benthamianus)
Number of subjects: 60
Study: 8085464

Group type: EXPERIMENTAL
Intervention: Moclobemide (300‐450 mg/day)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Fluoxetine (20‐40 mg/day)
Number of subjects: 209
Study: 2751139

Group type: EXPERIMENTAL
Intervention: 0.10 mg.kg‐1 caudal morphine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.067 mg.kg‐1 caudal morphine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.033 mg.kg‐1 caudal morphine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nasogastric drainage
Number of subjects: 32
Study: 1098499

Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Amodiaquine (2.0 g course)
Number of subjects: 47
Study: 31786695

Group type: EXPERIMENTAL
Intervention: Hetero- or homozygosity for the allelic variant TLR6 (P249S) in patients with large abscesses
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Homozygosity for the allelic variant TLR1 (R80T) in patients with large abscesses
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Hetero- or homozygosity for the allelic variant TLR1 (S248N) in patients with DFIs
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Polymorphisms in TLR1 and TLR6
Number of subjects: 253

Group type: COMPARATOR
Intervention: PEDIS infection score
Number of subjects: 253
Study: 31576433

Group type: EXPERIMENTAL
Intervention: Nivolumab 480 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nivolumab 960 mg
Number of subjects: 31
Study: 28295989

Group type: EXPERIMENTAL
Intervention: 5 mg/ml liquid formulation of 6-mercaptopurine (6-MP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 50 mg/ml liquid formulation of 6-mercaptopurine (6-MP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Marketed 50 mg 6-MP tablet
Number of subjects: 22
Study: 25181451

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) starting titration at 200 μg
Number of subjects: 442

Group type: COMPARATOR
Intervention: Fentanyl buccal tablet (FBT) starting titration at 100 μg
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Effective doses of FBT
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) at doses up to 800 μg
Number of subjects: 442
Study: 24490266

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg daily for 18 months)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 286
Study: 21474277

Group type: EXPERIMENTAL
Intervention: Expected relaxation (ER)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Expected arousal (EA)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Low-AS with expected relaxation (ER)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Low-AS with expected arousal (EA)
Number of subjects: 79
Study: 19087583

Group type: EXPERIMENTAL
Intervention: Damon3 self-ligating brackets
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 26
Study: 16581477

Group type: EXPERIMENTAL
Intervention: Warm-up exercise (WEx) before cold exposure
Number of subjects: 15

Group type: COMPARATOR
Intervention: Weight-bearing exercise before cold exposure
Number of subjects: 15
Study: 15252267

Group type: EXPERIMENTAL
Intervention: Modafinil 600-mg split dose (400 mg at 7 AM; 200 mg at noon)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Modafinil 400-mg once daily (7 AM) plus placebo (noon)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modafinil (both dosing strategies)
Number of subjects: 24
Study: 11511287

Group type: EXPERIMENTAL
Intervention: Atropine 1% ophthalmic solution
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 9266878

Group type: EXPERIMENTAL
Intervention: Immediate cytologic assessment during CT-guided FNAC (Group A, 110 patients)
Number of subjects: 220

Group type: COMPARATOR
Intervention: No immediate cytologic examination, only gross assessment by the surgeon (Group B, 110 patients)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Overall results for both groups
Number of subjects: 220
Study: 8016009

Group type: EXPERIMENTAL
Intervention: Naftopidil (50 mg, oral administration)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naftopidil (5 mg, intravenous infusion)
Number of subjects: 10
Study: 2648152

Group type: EXPERIMENTAL
Intervention: 10 ml or 50 ml of fish oil (3 or 15 g of n‐3 fatty acids)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 50 ml of safflower oil (39 g of n‐6 fatty acids)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 50 ml of a mixture of oils that approximated the types of fat present in the American diet
Number of subjects: 32